HIV Care Grant Program - Part B States/Territories Formula and AIDS Drug Assistance Program Formula and AIDS Drug Assistance Program Supplemental Awards

The HIV Care Grant Program - Part B States/Territories Formula and AIDS Drug Assistance Program Formula and AIDS Drug Assistance Program Supplemental Awards is administered by the Health Resources and Services Administration within the U.S. Department of Health and Human Services. This federal program is part of the broader Ryan White HIV/AIDS Program, which is designed to support access to care and treatment for individuals living with HIV, particularly those who are low income and uninsured or underinsured. The program operates as a formula-based funding mechanism, meaning that allocations are determined based on epidemiological and demographic data rather than competitive scoring alone. It is a longstanding federal initiative intended to strengthen public health infrastructure and improve health outcomes for people with HIV across states and territories. The primary purpose of this funding opportunity is to provide financial support to eligible states and territories to develop, maintain, and enhance comprehensive systems of HIV care. These systems are expected to include outpatient medical care, access to antiretroviral therapy, and supportive services that ensure continuity of care. A major component of the program is the AIDS Drug Assistance Program, which helps provide medications to individuals who might otherwise be unable to afford them. Supplemental funding may also be awarded to address emerging needs or disparities in access to care, including support for minority populations disproportionately affected by HIV. Funding under this program can be used for a wide range of allowable activities, including direct medical services, pharmaceutical access, care coordination, and program administration within federally established limits. The funding is designed to support integrated care systems that improve viral suppression rates and reduce HIV-related morbidity and mortality. While the opportunity does not require cost sharing or matching contributions from applicants, recipients must comply with federal regulations regarding the use of funds, reporting, and performance measurement. Eligibility for this opportunity is limited to state governments and certain territorial governments. Specifically, all 50 U.S. states, the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands are eligible to apply under this notice. Additional territories have separate but related funding opportunities under a different notice number. The program is not open to nonprofit organizations, individuals, or private entities, as it is designed to fund state-level public health systems that can administer HIV care programs at scale. The application process is expected to follow standard federal grant submission procedures through electronic systems such as Grants.gov. Applicants must submit their applications by the stated deadline, and late submissions are generally not accepted. While specific application components are not detailed in this forecast notice, applicants can expect to provide program plans, budget justifications, and documentation demonstrating their capacity to administer HIV care services. The estimated application due date is October 30, 2026, with submissions required by 11:59 PM Eastern Time on that date. Awards are anticipated to be issued by April 1, 2027, which also aligns with the expected project start date. The total estimated program funding is approximately 1.34 billion dollars, distributed across an expected 54 awards. The program operates on a recurring annual cycle, reflecting ongoing federal commitment to HIV care infrastructure. Contact information for the program includes Erin Nortrup at the Health Resources and Services Administration, who can be reached by phone or email for additional inquiries regarding the funding opportunity. This forecasted notice provides advance awareness to potential applicants, allowing them to prepare for the formal release of the funding opportunity announcement.